Boulevard Bio: Funding, Investors & Team (Oct 2026)
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for cardiometabolic disorders.
Boulevard Bio has raised $65.0M across 1 funding round on record, the most recent a Seed of $65.0M announced in Aug 2026.
That round is above the $47M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Boulevard Bio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Boulevard Bio Funding Rounds
Boulevard Bio Investors
Boulevard Bio Funding Compared to Other Biotechnology Startups
Boulevard Bio's latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Biotechnology Startups Like Boulevard Bio
Companies Similar to Boulevard Bio
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration…
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
Boulevard Bio Funding FAQs
What does Boulevard Bio do?
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for cardiometabolic disorders.
How much funding has Boulevard Bio raised?
Boulevard Bio has raised $65.0M across 1 round on record. The most recent is a Seed of $65.0M announced in Aug 2026.
When did Boulevard Bio last raise funding?
Boulevard Bio's most recent funding round on record is a Seed of $65.0M, announced in Aug 2026.
Who has invested in Boulevard Bio?
Investors on record for Boulevard Bio include Deerfield Management.
How many employees does Boulevard Bio have?
Boulevard Bio is in the 1-10 employee band.
How does Boulevard Bio's funding compare to other Biotechnology startups?
Boulevard Bio's latest round of $65.0M is above the $47M median round size for Biotechnology companies on FundedIQ across 5 tracked companies over the last two years.
About FundedIQ's Boulevard Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Boulevard Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.